Optional continuing education contact hours can be received if the survey is completed after watching the video.
Please view each individual video for updated instructions on how to receive this continuing education credit.
This program will highlight the risk and management associated with hereditary polyposis genes beyond APC and discuss current literature and emerging data surrounding this syndrome.
This program highlights unique scenarios in interpreting germline TP53 variants and discusses appropriate follow-up approaches for patient management.
This program details the initiatives of the Cancer Moonshot program and discusses evolving guidelines of high-risk management for patients with hereditary cancer syndromes and cancer survivors..
This program examines breast cancer genes beyond BRCA 1 and BRCA 2 and will focus on risk and medical management associated with these mutations.
This program will examine somatic and germline testing in clinical oncology settings and focus on differentiation and clinical application of genomic tests to improve patient care and outcomes.
This program will examine implicit bias within healthcare and discuss its impact on the providers and patients while introducing strategies for equitable care to improve patient outcomes.
This program will evaluate various risk assessment methods and focus on risk reducing therapies for patients with an increased risk of breast cancer.
This program will discuss risk assessment, treatment and opportunities to increase access for genetic testing for patients at risk or diagnosed with prostate cancer.
This program will discuss hereditary renal tumor syndromes and highlight criteria for identifying patients at risk for hereditary renal cell carcinoma as well as discuss management for affected patients.
This program will highlight challenges in providing equitable care for sexual and gender minority patients and examine strategies to overcome these challenges within a clinical and research construct.
This program will outline current methods to identify patients at risk for hereditary colorectal cancer and discuss potential strategies to improve access for genetic testing and treatment for these patients.
This program will define and examine disparities in digital health literacy and provide solutions to improve education and communication for patients with cancer.
This webinar will highlight updates in cancer treatment associated with genomic and genetic testing and address challenges and benefits of improving clinical trial enrollment for patients with hereditary cancer.
This webinar will examine the American Society of Breast Surgeons (ASBrS) consensus guidelines on genetic testing for all patients with breast cancer and discuss its implications on local and systemic treatment recommendations.
More webinars coming soon